| Literature DB >> 24956486 |
Robert Price1, Azadeh Poursaid2, Hamidreza Ghandehari3.
Abstract
Recombinant polymers provide a high degree of molecular definition for correlating structure with function in controlled release. The wide array of amino acids available as building blocks for these materials lend many advantages including biorecognition, biodegradability, potential biocompatibility, and control over mechanical properties among other attributes. Genetic engineering and DNA manipulation techniques enable the optimization of structure for precise control over spatial and temporal release. Unlike the majority of chemical synthetic strategies used, recombinant DNA technology has allowed for the production of monodisperse polymers with specifically defined sequences. Several classes of recombinant polymers have been used for controlled drug delivery. These include, but are not limited to, elastin-like, silk-like, and silk-elastinlike proteins, as well as emerging cationic polymers for gene delivery. In this article, progress and prospects of recombinant polymers used in controlled release will be reviewed.Entities:
Keywords: Controlled release; Elastin-like Polypeptides (ELP); Recombinant Cationic Polymers (RCP); Recombinant polymers; Silk-elastinlike Protein Polymers (SELP); Silk-like Polypeptides (SLP)
Mesh:
Substances:
Year: 2014 PMID: 24956486 PMCID: PMC4142100 DOI: 10.1016/j.jconrel.2014.06.016
Source DB: PubMed Journal: J Control Release ISSN: 0168-3659 Impact factor: 9.776